SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 137 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,261 | -47.5% | 155,714 | -24.3% | 0.02% | -37.1% |
| Q2 2023 | $4,306 | +229.5% | 205,718 | +232.5% | 0.04% | +218.2% |
| Q1 2023 | $1,307 | -99.9% | 61,873 | +5.8% | 0.01% | -38.9% |
| Q3 2022 | $1,405,000 | +21.0% | 58,466 | -3.1% | 0.02% | +28.6% |
| Q2 2022 | $1,161,000 | +239.5% | 60,357 | +206.8% | 0.01% | +250.0% |
| Q1 2022 | $342,000 | +47.4% | 19,673 | +89.9% | 0.00% | +33.3% |
| Q1 2021 | $232,000 | – | 10,359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 8,076 | $174,522 | 0.01% |
| MASSMUTUAL TRUST CO FSB/ADV | 46 | $994 | 0.00% |